Episode 64 - Kristof Vercruysse - CEO of TargED Biopharmaceuticals

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.On this episode we were joined by Kristof Vercruysse, CEO of TargED Biopharmaceuticals, an Utrecht-based biotech who're developing a novel Targeted Enzyme Delivery approach to Thrombolysis. On this episode, we discuss the current standard of care in indications such as TTP & Acute Ischemic Stroke and why TargED's platform represents a potential paradigm-shift for patients.

Episode metadata supplied by the publisher feed · Published Aug 28, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 64 - Kristof Vercruysse - CEO of TargED Biopharmaceuticals

0:00 29:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 29 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on August 28, 2025.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!